STME (Stimcell Energetics) Cyclically Adjusted PB Ratio: (As of Jul. 09, 2026)


STME Stimcell Energetics Inc STME
26 GF Score
Price $0.31
! 4 Warning Signs
View Full Analysis

What is Stimcell Energetics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Stimcell Energetics  (OTCPK:STME) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Stimcell Energetics Cyclically Adjusted PB Ratio Related Terms


Stimcell Energetics Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Stimcell Energetics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stimcell Energetics Cyclically Adjusted PB Ratio Chart

Stimcell Energetics Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Stimcell Energetics Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STME vs NVNO, TRIB, AIDX: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Stimcell Energetics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stimcell Energetics Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Stimcell Energetics's Cyclically Adjusted PB Ratio falls into.


STME
26GF Score
Stimcell Energetics Inc STME
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stimcell Energetics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Stimcell Energetics's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2026 is calculated as:

For example, Stimcell Energetics's adjusted Book Value per Share data for the three months ended in Feb. 2026 was:

Adj_Book=Book Value per Share/CPI of Feb. 2026 (Change)*Current CPI (Feb. 2026)
=-0.08/131.0772*131.0772
=-0.080

Current CPI (Feb. 2026) = 131.0772.

Stimcell Energetics Quarterly Data

Book Value per Share CPI Adj_Book
201605 -0.684 101.765 -0.881
201608 -0.794 101.686 -1.024
201611 -0.187 101.607 -0.241
201702 -0.288 102.476 -0.368
201705 -0.436 103.108 -0.554
201708 -0.384 103.108 -0.488
201711 -0.206 103.740 -0.260
201802 -0.284 104.688 -0.356
201805 -0.363 105.399 -0.451
201808 -0.446 106.031 -0.551
201811 -0.487 105.478 -0.605
201902 -0.555 106.268 -0.685
201905 -0.601 107.927 -0.730
201908 -0.362 108.085 -0.439
201911 -0.395 107.769 -0.480
202002 -0.394 108.559 -0.476
202005 -0.408 107.532 -0.497
202008 -0.376 108.243 -0.455
202011 -0.425 108.796 -0.512
202102 -0.477 109.745 -0.570
202105 -0.381 111.404 -0.448
202108 -0.370 112.668 -0.430
202111 -0.407 113.932 -0.468
202202 -0.439 115.986 -0.496
202205 -0.479 120.016 -0.523
202208 -0.502 120.569 -0.546
202211 -0.524 121.675 -0.564
202302 -0.549 122.070 -0.590
202305 -0.569 124.045 -0.601
202308 -0.589 125.389 -0.616
202311 -0.602 125.468 -0.629
202402 -0.036 125.468 -0.038
202405 -0.042 127.601 -0.043
202408 -0.046 127.838 -0.047
202411 -0.050 127.838 -0.051
202502 -0.054 128.786 -0.055
202505 -0.062 129.813 -0.063
202508 -0.068 130.208 -0.068
202511 -0.074 130.682 -0.074
202602 -0.080 131.077 -0.080

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stimcell Energetics Business Description

Address 1130 Pender Street, West, Suite 820, Vancouver, BC, CAN, V6E 4A4
Stimcell Energetics Inc is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications, including, but not limited to: aging, diabetes, high blood pressure, neuropathy, and kidney function. The company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
26GF Score

Get the complete analysis for STME

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price